presented by Barbara Gladson
This course summarizes the pathophysiology of cardiac disease with regard to its pharmacologic treatment. Students will learn about nitroglycerin and how to use the patient’s response to differentiate angina from an MI. Students will also learn about drugs for high cholesterol and how to distinguish their side effects from true musculoskeletal impairments. The course will also cover drug treatment for congestive heart failure and explain the limitations of antiarrhythmic drugs.
Dr. Gladson has earned a BS from the University of Pennsylvania in Occupational Therapy, a MS degree in Physical Therapy from Columbia and a PhD in Pharmacology from the Rutgers Graduate School of Biomedical Sciences. She is the Associate Dean for Academic Affairs in the School of Health Professions, and the Director of the Rutgers BioPharma Educational Initiative, MS in Clinical Trial Sciences, which educates individuals seeking to enter the Pharmaceutical Industry. Dr. Gladson's areas of teaching include Medical Pathophysiology, Pharmacokinetics, Cultural Diversity in Clinical Trials and Pharmacology. She has developed several web-based courses and has recently completed a textbook in pharmacology. Dr. Gladson’s research interests include methodology to improve subject recruitment efforts in clinical trials as well as in educating the public on the value of participating in a drug trial.
In chapter one, Barbara Gladson will define Angina, Mechanism of action of Nitroglycerin, and the administration of sublingual Nitro to reduce Angina.
Chapter two will discuss the role of platelet aggregator inhibitors, anticoagulants, and thrombolytics in coronary heart disease and their implications for therapeutic interventions. Barbara Gladson will cover the controversial role of aspirin in preventing cardiac events and explain the dosing regimen for a patient who takes NSAIDs for arthritis and low-dose aspirin for cardio protection.
Barbara Gladson will explain the role of statins in reducing high cholesterol and assess patient response to determine statin related problems in this chapter. She will also list agents used to improve organ perfusion in Congestive Heart Disease and
In the final lecture chapter, Gladson will review heart failure and the stages of therapy. She will also cover cognitive function in association with heart failure and other conditions connected to it.
A question and answer session with Barbara Gladson and PT Holly Tanner, in which they will discuss the topics cover in this course and how they relate to practice.